Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Zelira Therapeutics ( (AU:ZLD) ) just unveiled an announcement.
Zelira Therapeutics has secured a $1 million At-the-Market (ATM) funding facility with Securities Vault Pty Ltd to support its clinical programs and growth strategy. This facility provides Zelira with flexible access to equity capital over the next 12 months, allowing the company to align capital needs with operational activities while maintaining control over the timing and terms of capital issuances. The ATM agreement enhances Zelira’s financial flexibility and positions the company to advance its strategic objectives without incurring significant dilution or complex financing mechanisms.
More about Zelira Therapeutics
Zelira Therapeutics Ltd is a global leader in the development and commercialization of clinically validated cannabinoid-based medicines. The company focuses on advancing key clinical programs and implementing growth strategies in the cannabinoid medicine industry.
YTD Price Performance: -22.34%
Average Trading Volume: 380
Technical Sentiment Signal: Buy
Current Market Cap: $3.43M
Find detailed analytics on ZLD stock on TipRanks’ Stock Analysis page.